Intuitive Surgical Gross Profit 2010-2024 | ISRG
Intuitive Surgical annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Intuitive Surgical gross profit for the quarter ending September 30, 2024 was $1.374B, a 17.71% increase year-over-year.
- Intuitive Surgical gross profit for the twelve months ending September 30, 2024 was $5.269B, a 15.48% increase year-over-year.
- Intuitive Surgical annual gross profit for 2023 was $4.73B, a 12.71% increase from 2022.
- Intuitive Surgical annual gross profit for 2022 was $4.196B, a 6% increase from 2021.
- Intuitive Surgical annual gross profit for 2021 was $3.959B, a 38.35% increase from 2020.
| Intuitive Surgical Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $4,730 |
| 2022 | $4,196 |
| 2021 | $3,959 |
| 2020 | $2,861 |
| 2019 | $3,110 |
| 2018 | $2,604 |
| 2017 | $2,202 |
| 2016 | $1,893 |
| 2015 | $1,578 |
| 2014 | $1,414 |
| 2013 | $1,594 |
| 2012 | $1,570 |
| 2011 | $1,274 |
| 2010 | $1,030 |
| 2009 | $751 |
| Intuitive Surgical Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,374 |
| 2024-06-30 | $1,373 |
| 2024-03-31 | $1,245 |
| 2023-12-31 | $1,277 |
| 2023-09-30 | $1,167 |
| 2023-06-30 | $1,172 |
| 2023-03-31 | $1,113 |
| 2022-12-31 | $1,111 |
| 2022-09-30 | $1,052 |
| 2022-06-30 | $1,023 |
| 2022-03-31 | $1,010 |
| 2021-12-31 | $1,061 |
| 2021-09-30 | $971 |
| 2021-06-30 | $1,024 |
| 2021-03-31 | $903 |
| 2020-12-31 | $896 |
| 2020-09-30 | $724 |
| 2020-06-30 | $503 |
| 2020-03-31 | $738 |
| 2019-12-31 | $896 |
| 2019-09-30 | $786 |
| 2019-06-30 | $759 |
| 2019-03-31 | $670 |
| 2018-12-31 | $736 |
| 2018-09-30 | $642 |
| 2018-06-30 | $632 |
| 2018-03-31 | $594 |
| 2017-12-31 | $634 |
| 2017-09-30 | $568 |
| 2017-06-30 | $530 |
| 2017-03-31 | $470 |
| 2016-12-31 | $530 |
| 2016-09-30 | $487 |
| 2016-06-30 | $471 |
| 2016-03-31 | $405 |
| 2015-12-31 | $459 |
| 2015-09-30 | $396 |
| 2015-06-30 | $387 |
| 2015-03-31 | $337 |
| 2014-12-31 | $393 |
| 2014-09-30 | $361 |
| 2014-06-30 | $344 |
| 2014-03-31 | $315 |
| 2013-12-31 | $398 |
| 2013-09-30 | $357 |
| 2013-06-30 | $405 |
| 2013-03-31 | $434 |
| 2012-12-31 | $438 |
| 2012-09-30 | $390 |
| 2012-06-30 | $386 |
| 2012-03-31 | $356 |
| 2011-12-31 | $363 |
| 2011-09-30 | $326 |
| 2011-06-30 | $307 |
| 2011-03-31 | $279 |
| 2010-12-31 | $282 |
| 2010-09-30 | $251 |
| 2010-06-30 | $257 |
| 2010-03-31 | $241 |
| 2009-12-31 | $233 |
| 2009-09-30 | $199 |
| 2009-06-30 | $190 |
| 2009-03-31 | $129 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $186.791B | $7.124B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $200.449B | 24.45 |
| Edwards Lifesciences (EW) | United States | $44.123B | 28.02 |
| Alcon (ALC) | Switzerland | $41.807B | 27.97 |
| IQVIA Holdings (IQV) | United States | $35.805B | 19.73 |
| IDEXX Laboratories (IDXX) | United States | $33.758B | 39.76 |
| DexCom (DXCM) | United States | $31.263B | 47.08 |
| Waters (WAT) | United States | $21.860B | 32.32 |
| STERIS (STE) | Ireland | $20.481B | 23.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.736B | 0.00 |
| Hologic (HOLX) | United States | $16.260B | 17.56 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.386B | 13.74 |
| Sysmex ADR (SSMXY) | Japan | $11.751B | 0.00 |
| Globus Medical (GMED) | United States | $11.252B | 28.49 |
| Penumbra (PEN) | United States | $9.308B | 91.18 |
| Masimo (MASI) | United States | $9.076B | 43.92 |
| Glaukos (GKOS) | United States | $8.319B | 0.00 |
| Teleflex (TFX) | United States | $8.274B | 13.20 |
| Integer Holdings (ITGR) | United States | $4.484B | 25.41 |
| PROCEPT BioRobotics (PRCT) | United States | $4.236B | 0.00 |
| Inari Medical (NARI) | United States | $3.246B | 0.00 |
| Veracyte (VCYT) | United States | $3.169B | 95.09 |
| LivaNova (LIVN) | United Kingdom | $2.584B | 14.92 |
| Nihon Kohden (NHNKY) | Japan | $2.392B | 18.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.358B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.084B | 18.74 |
| TransMedics (TMDX) | United States | $2.071B | 65.64 |
| Integra LifeSciences Holdings (IART) | United States | $1.682B | 8.79 |
| RxSight (RXST) | United States | $1.357B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.326B | 0.00 |
| Artivion (AORT) | United States | $1.194B | 79.11 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.739B | 12.56 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.91 |
| IRadimed (IRMD) | United States | $0.693B | 37.43 |
| AxoGen (AXGN) | United States | $0.688B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.573B | 30.14 |
| SiBone (SIBN) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.408B | 22.08 |
| AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.352B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| CVRx (CVRX) | United States | $0.294B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.142B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| Spectral Diagnostics (EDTXF) | Canada | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| 908 Devices (MASS) | United States | $0.072B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Neuronetics (STIM) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.023B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |